GHRH AnalogHover to zoomQualified Research Reference
CJC-1295
CJC-1295 is documented for controlled research models and literature-based evaluation only.
- Regular
- $54.99
- Elite Member−10%
- $49.49
CJC-1295 is a synthetic growth-hormone-releasing hormone analog supplied as a lyophilized research peptide. Prepared for laboratory investigation.
Common research topics include GHRH receptor signaling, pulsatile growth hormone release, and endocrine axis modeling.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
CJC-1295: investigational profile.
Research Mechanism
A synthetic GHRH analog investigated for pituitary GHRH-receptor engagement and pulsatile growth-hormone release. Almost always studied alongside Ipamorelin to model combined GHRH + GHS-R stimulation.
Investigational Profile
GHRH-analog research has been published continuously since the mid-2000s across endocrine and body-composition models.
Research Study Window
Laboratory protocols commonly run four to twelve weeks so pulsatile GH endpoints and downstream axis markers can be tracked across a full observation window.
Pairs With
Ipamorelin
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C165H269N47O46
- Molar Mass
- 3647.1 g/mol
- Amino Acid Sequence
- H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-OH
- Synonyms
- Modified GRF (1-29), CJC-1295 no-DAC
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
